Cumberland Pharmaceuticals (CPIX) Depreciation & Amortization (CF) (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 23.72% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (down 8.23% YoY), and the FY2025 full-year result was $4.1 million, down 15.45% from the prior year.
• Depreciation & Amortization (CF) advanced to $1.3 million in Q1 2026, from $1.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.7 million in Q1 2022 to a low of $511483.0 in Q4 2022.
• A 5-year average of $1.2 million and a median of $1.2 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) sank 52.51% in 2022 and soared 141.12% in 2023, its largest moves.
• Tracing CPIX's Depreciation & Amortization (CF) over 5 years: stood at $511483.0 in 2022, then soared by 141.12% to $1.2 million in 2023, then increased by 21.34% to $1.5 million in 2024, then plunged by 30.37% to $1.0 million in 2025, then increased by 22.5% to $1.3 million in 2026.
• Business Quant data shows CPIX's Depreciation & Amortization (CF) at $1.3 million in Q1 2026, $1.0 million in Q4 2025, and $1.0 million in Q3 2025.